Diagnostic accuracies of screening for atrial fibrillation by cardiac nurses versus radiographers.

atrial fibrillation diagnostic accuracy electrocardiography screening

Journal

Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219

Informations de publication

Date de publication:
Historique:
received: 01 10 2018
revised: 11 12 2018
accepted: 03 02 2019
entrez: 19 4 2019
pubmed: 19 4 2019
medline: 19 4 2019
Statut: epublish

Résumé

We examined the diagnostic accuracy of single-lead ECG as assessed by radiographers and 12-lead ECG as assessed by cardiac nurses for the diagnosis of atrial fibrillation (AF). Based on the Danish Cardiovascular Screening Trial, we conducted a population-based, cross-sectional study of 1338 randomly selected Danish men aged 65-74 years with no exclusion criteria. The participants were screened with single-lead ECG during a CT scan assessed by radiographers and 12-lead ECG assessed by cardiac nurses. The diagnostic accuracy was evaluated compared with that produced by a 12-lead ECG assessed by two consenting cardiologists. The study identified 68 participants with ongoing AF, of whom 60 had self-reported AF and 8 had AF detected in the screening. Single-lead ECG assessed for AF by radiographers had a sensitivity of 60.3% (95% CI 47.7 to 72.0), specificity of 97.2% (95% CI 96.2 to 98.1), positive predictive value (PPV) of 53.9% (95% CI 42.1 to 65.5) and negative predictive value (NPV) of 97.9% (95% CI 96.9 to 98.6). 12-lead ECG assessed by cardiac nurses had a sensitivity of 97.1% (95% CI 89.8 to 99.6), specificity of 100% (95% CI 99.7 to 100), PPV of 100% (95% CI 94.6 to 100) and NPV of 99.8% (95% CI 99.4 to 100). Single-lead ECG assessed by radiographers had a moderate sensitivity and PPV but a very high specificity and NPV. Using radiographers may be acceptable for opportunistic screening, in particular if radiographers are thoroughly trained. Thus, 12-lead ECG assessed by cardiac nurses is a potential diagnostic method for the detection of AF.

Identifiants

pubmed: 30997131
doi: 10.1136/openhrt-2018-000942
pii: openhrt-2018-000942
pmc: PMC6443120
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e000942

Déclaration de conflit d'intérêts

Competing interests: LF has been a member of the advisory boards for BMS and Pfizer, and has received speaker fees from Bayer, BMS, Boehringer Ingelheim, MSD and Pfizer.

Références

Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74
pubmed: 16202350
Circulation. 2007 Jun 19;115(24):3050-6
pubmed: 17548732
Stroke. 2009 Jan;40(1):235-40
pubmed: 18757287
Eur Heart J. 2013 Sep;34(35):2746-51
pubmed: 23900699
Circulation. 2014 Feb 25;129(8):837-47
pubmed: 24345399
Thromb Haemost. 2014 Jun;111(6):1167-76
pubmed: 24687081
BMC Fam Pract. 2014 Jun 09;15:113
pubmed: 24913608
Am J Cardiol. 2014 Oct 1;114(7):1046-8
pubmed: 25212546
Circulation. 2015 Jun 23;131(25):2176-84
pubmed: 25910800
Eur J Prev Cardiol. 2016 Aug;23(12):1330-8
pubmed: 26464292
Trials. 2015 Dec 05;16:554
pubmed: 26637993
Heart Rhythm. 2016 Jul;13(7):1418-24
pubmed: 26961300
J Am Heart Assoc. 2016 Jul 21;5(7):
pubmed: 27444506
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Europace. 2017 Feb 1;19(2):169-179
pubmed: 28172715
Europace. 2017 Sep 1;19(9):1449-1453
pubmed: 28339578
Circulation. 2017 May 9;135(19):1851-1867
pubmed: 28483832
Lancet. 2017 Nov 18;390(10109):2256-2265
pubmed: 28859943
Europace. 2017 Oct 1;19(10):1589-1623
pubmed: 29048522
PLoS One. 2017 Nov 13;12(11):e0188086
pubmed: 29131836
Europace. 2018 Mar 1;20(3):395-407
pubmed: 29300976
Eur Heart J. 2018 Apr 21;39(16):1407-1415
pubmed: 29340587
JAMA. 2018 Aug 7;320(5):478-484
pubmed: 30088016

Auteurs

Lærke Marius Kvist (LM)

Diagnostic Centre, Regionshospitalet Silkeborg, Silkeborg, Denmark.

Nicklas Vinter (N)

Diagnostic Centre, Regionshospitalet Silkeborg, Silkeborg, Denmark.
Department of Clinical Medicine, Aarhus Universitet, Aarhus, Denmark.

Grazina Urbonaviciene (G)

Diagnostic Centre, Regionshospitalet Silkeborg, Silkeborg, Denmark.
Department of Clinical Medicine, Aarhus Universitet, Aarhus, Denmark.

Jes Sanddal Lindholt (JS)

Department of Cardiothoracic and Vascular Surgery, Elitary Research Centre of Individualized Medicine in Arterial Diseases (CIMA), Odense Universitetshospital, Odense, Denmark.

Axel Cosmus Pyndt Diederichsen (ACP)

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Lars Frost (L)

Department of Medicine, Silkeborg Regional Hospital and Cardiovascular Research Centre Viborg and Silkeborg Hospital and Institute of Clinical Medicine, Aarhus University Hospital Denmark, Silkeborg, Denmark.

Classifications MeSH